Newsroom

Newsroom

PEI Keynote Interview

Media Coverage

March 1, 2022
Strong partnerships are critical to developing businesses at scale throughout key markets in Europe, say Marco Herbst, Greg Laï, Christian Rochat and Eric Rouzier at Clayton, Dubilier & Rice
Call In Podcast Logo.

Media Coverage

February 24, 2022
Episode 10 of the Call In podcast features a conversation with Julian Francis, President and CEO of Beacon Building Products – the largest publicly traded distributor of roofing materials and complementary building products in the U.S. and Canada...
Vera Whole Health Logo.

Press Release

February 17, 2022
Vera Whole Health, Inc. ("Vera") announced today that it has successfully completed its previously announced acquisition of Castlight Health, Inc. ("Castlight") at a price of $2.05 per share, net to the seller, in cash, without interest and subject...
Andrea Peiro

Press Release

February 9, 2022
Clayton, Dubilier & Rice announced the appointment of Andrea Peiro, an experienced technology professional and successful entrepreneur, as an Operating Principal. In his new role, Mr. Peiro will be engaged in evaluating investments and help...
Hand holding a seedling.

Perspectives

February 7, 2022
The conversation about private equity and environmental, social and corporate governance (ESG) has been largely around reporting guidelines and metrics. We believe private equity is well-positioned to drive and scale ESG best practices. The...
Anand Shah, M.D.

Press Release

February 3, 2022
Clayton, Dubilier & Rice today announced Anand Shah, M.D., former U.S. Food and Drug Administration (“FDA”) Deputy Commissioner for Medical and Scientific Affairs, as an Operating Advisor to CD&R funds. Dr. Shah will work with CD&R’s...
Vera Whole Health and Castlight Health logos

Press Release

January 5, 2022
Castlight Health, Inc. (“Castlight”) (NYSE: CSLT), a leading healthcare data and navigation company, and Vera Whole Health, Inc. (“Vera”), a pioneer in advanced primary care, today jointly announced an agreement under which the companies will...
Jon Selib Headshot

Press Release

December 21, 2021
Clayton, Dubilier & Rice today announced the appointment of Jon Selib, former Senior Vice President of Global Policy & Public Affairs at Pfizer, as Managing Director and Global External Affairs Leader. In his new role, which will take effect...
Belron logo

Press Release

December 17, 2021
Clayton, Dubilier & Rice Fund X today announced the sale of its investment in Belron, a worldwide leader in vehicle glass repair and replacement. The two-part transaction included the sale of approximately 39% of CD&R Fund X’s stake to funds...
Gordon Riske

Press Release

December 13, 2021
Clayton, Dubilier & Rice announced today that Gordon Riske will be engaged as an Operating Advisor to CD&R funds effective January 1, 2022 after he steps down as Chief Executive Officer of KION GROUP AG, a global provider of materials...

Events

December 7, 2021
CD&R Chairman Don Gogel joined Professor Florin Vasvari, Academic Director of the Institute of Entrepreneurship and Private Capital (IEPC), in a London Business School fireside chat titled, “In conversation with Don Gogel: private capital in...
Screen shot from video
Play Video

Events

December 7, 2021
CD&R Chairman Don Gogel discusses trends and opportunities in private capital with Professor Florin Vasvari, Academic Director of the Institute of Entrepreneurship and Private Capital (IEPC) at London Business School. The video below...
Sirius Computer Solutions logo

Press Release

December 2, 2021
Clayton, Dubilier & Rice today completed the previously announced sale of Sirius Computer Solutions, a leading provider of secure, mission-critical technology-based solutions for corporate and institutional customers, to CDW (Nasdaq: CDW). The...
Private equity’s future is bright.

Media Coverage

December 1, 2021
Growing capital flows are helping to increase sellers’ understanding of the PE ownership model and widen the pool of potential targets, say CD&R’s CEO and co-presidents
Dave Novak

Events

November 30, 2021
Dave Novak, Co-President of CD&R, spoke with Dushy Sivanithy, Managing Director and Head of Secondaries at CPPIP, at Sahar Global Summits’ 5th Annual Private Equity and Secondaries Investor Summit. Mr. Novak discussed the asset classes’ growth...
Solenis Logo.

Press Release

November 9, 2021
Clayton, Dubilier & Rice today announced the completion of the sale of Solenis, a leading global supplier of specialty chemicals and services for water treatment applications, to Platinum Equity. CD&R funds, which along with management owned...
Jillian Griffiths

Press Release

November 4, 2021
Clayton, Dubilier & Rice announced today the appointment of Jillian Griffiths as Chief Financial Officer. Ms. Griffiths joined CD&R in 2015 as a Partner serving as Chief Operating Officer. Over the past six years she has successfully led the...
people listening to a presentation

Events

November 1, 2021
Dave Novak, Co-President of CD&R, and Roberto Quarta, Chairman of CD&R Europe, delivered the keynote interview at SuperReturn’s 2021 Middle East Conference, which convened an intimate group of investors from the Middle East and beyond. The...
MCC

Press Release

November 1, 2021
Clayton, Dubilier & Rice completed the previously announced combination of Fort Dearborn Company and Multi-Color Corporation, creating the world’s largest prime label supplier by revenues. Terms of the transaction were not disclosed. With...
PwC

Press Release

October 19, 2021
Clayton, Dubilier & Rice and PwC today announced an agreement under which CD&R funds will acquire PwC's Global Mobility Tax and Immigration Services business. The business is the global leader in employee tax, immigration, business travel,...
Certain persons quoted in certain news items are advisors to CD&R’s funds or executives, employees, directors or persons serving in similar capacities in CD&R’s funds’ portfolio companies, or other persons or organizations who have or may in the future have business or other relationships with CD&R or its funds. Such relationships and any compensation associated with them create a conflict of interest, as the relationship and/or the compensation incentivizes such person to endorse CD&R or its funds.